Commonwealth Equity Services’s ESSA Pharma EPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-29,195
Closed -$834K 3604
2021
Q2
$834K Hold
29,195
﹤0.01% 2053
2021
Q1
$848K Sell
29,195
-100
-0.3% -$2.32K ﹤0.01% 1919
2020
Q4
$349K Hold
29,295
﹤0.01% 2446
2020
Q3
$202K Buy
29,295
+5,025
+21% +$34.1K ﹤0.01% 2711
2020
Q2
$150K Buy
24,270
+3,250
+15% +$15.4K ﹤0.01% 2695
2020
Q1
$84K Hold
21,020
﹤0.01% 2613
2019
Q4
$115K Buy
21,020
+9,520
+83% +$44.3K ﹤0.01% 2723
2019
Q3
$38K Buy
+11,500
New +$28.4K ﹤0.01% 2760

Other funds holding EPIX

Commonwealth Equity Services's EPIX Position: Q3 2021 in Review

Commonwealth Equity Services sold out of ESSA Pharma (EPIX) in Q3 2021, closing a stake of 29,195 shares — an estimated $834K sold.

Commonwealth Equity Services first reported a position in EPIX in Q3 2019 and held it in 8 quarters. The position peaked at $848K in Q1 2021. 75 funds tracked by Wall St. Rank hold EPIX as of Q3 2021.

  • Commonwealth Equity Services reported no remaining ESSA Pharma position as of Q3 2021 after selling out during the quarter.
  • Commonwealth Equity Services sold 29,195 ESSA Pharma shares in Q3 2021, an estimated $834K.
  • Commonwealth Equity Services first reported a position in ESSA Pharma in Q3 2019 and held it in 8 quarters.
  • Commonwealth Equity Services's ESSA Pharma position peaked at $848K in Q1 2021.
  • 75 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2021.

Based on Commonwealth Equity Services's 13F filing for Q3 2021, filed 29 Oct 2021.